DrugRepV Browse Page

DrugRepV browse page allows user to take a glance of the particular antiviral agent.Fields in the webpage is hylerlinked ot various external repositories like DrugBank, PubChem, Clinicaltrials.gov,and PubMed.User can explore the biological, Clinical, Chemical, and Structural details of every repurposed drug candidate.By clicking on the table header arrows, user can sort entries in ascending or descending order.


Total number of Records for Visual assay are 45

DrugRepV_ID	Antiviral Name	Drug type	Primary Indication	Secondary Indication	Strain	Pathways	Assay	Activity	Clinical Status	References
DrugRepV_7426	6-Azauridine	NA	Cancer	West Nile virus	New York		Visual assay	Decrease (50 %)	NA	12076755
DrugRepV_7427	6-Azauridine	NA	Cancer	West Nile virus	Uganda strain B 956		Visual assay	Decrease (50 %)	NA	12076755
DrugRepV_7428	6-Azauridine triacetate	NA	NA	West Nile virus	New York		Visual assay	Decrease (50 %)	NA	12076755
DrugRepV_7429	6-Azauridine triacetate	NA	NA	West Nile virus	Uganda strain B 956		Visual assay	Decrease (50 %)	NA	12076755
DrugRepV_7430	Pyrazofurin	NA	NA	West Nile virus	New York		Visual assay	Decrease (50 %)	NA	12076755
DrugRepV_7431	Pyrazofurin	NA	NA	West Nile virus	Uganda strain B 956		Visual assay	Decrease (50 %)	NA	12076755
DrugRepV_7432	2-Thio-6-azauridine	NA	NA	West Nile virus	New York		Visual assay	Decrease (50 %)	NA	12076755
DrugRepV_7433	2-Thio-6-azauridine	NA	NA	West Nile virus	Uganda strain B 956		Visual assay	Decrease (50 %)	NA	12076755
DrugRepV_7442	3-Deazaguanosine	NA	NA	West Nile virus	New York		Visual assay	Decrease (50 %)	NA	12076755
DrugRepV_7443	Mycophenolic Acid	Antineoplastic and Immunomodulating Agents	Organ rejection (immunosuppressants)	West Nile virus	New York		Visual assay	Decrease (50 %)	Approved	12076755
DrugRepV_7444	Mycophenolic Acid	Antineoplastic and Immunomodulating Agents	Organ rejection (immunosuppressants)	West Nile virus	Uganda strain B 956		Visual assay	Decrease (50 %)	Approved	12076755
DrugRepV_7445	Ribamidine	NA	NA	West Nile virus	New York		Visual assay	Decrease (50 %)	NA	12076755
DrugRepV_7446	Ribamidine	NA	NA	West Nile virus	Uganda strain B 956		Visual assay	Decrease (50 %)	NA	12076755
DrugRepV_7447	Ribavirin	Antiinfectives For Systemic Use	Hepatitis C virus	West Nile virus	New York		Visual assay	Decrease (50 %)	Approved	12076755
DrugRepV_7448	Ribavirin	Antiinfectives For Systemic Use	Hepatitis C virus	West Nile virus	Uganda strain B 956		Visual assay	Decrease (50 %)	Approved	12076755
DrugRepV_7449	Selenazofurin	NA	NA	West Nile virus	New York		Visual assay	Decrease (50 %)	NA	12076755
DrugRepV_7450	Selenazofurin	NA	NA	West Nile virus	Uganda strain B 956		Visual assay	Decrease (50 %)	NA	12076755
DrugRepV_7451	Tiazofurin	Antineoplastic and Immunomodulating Agents	Cancer	West Nile virus	New York		Visual assay	Decrease (50 %)	Experimental	12076755
DrugRepV_7452	beta-Methylene TAD	NA	NA	West Nile virus	New York		Visual assay	Decrease (50 %)	NA	12076755
DrugRepV_7453	beta-Methylene TAD	NA	NA	West Nile virus	Uganda strain B 956		Visual assay	Decrease (50 %)	NA	12076755
DrugRepV_7466	3-Deazauridine	NA	NA	West Nile virus	New York		Visual assay	Decrease (50 %)	NA	12076755
DrugRepV_7467	3-Deazauridine	NA	NA	West Nile virus	Uganda strain B 956		Visual assay	Decrease (50 %)	NA	12076755
DrugRepV_7468	Cyclopentenylcytosine	NA	NA	West Nile virus	New York		Visual assay	Decrease (50 %)	NA	12076755
DrugRepV_7469	Cyclopentenylcytosine	NA	NA	West Nile virus	Uganda strain B 956		Visual assay	Decrease (50 %)	NA	12076755
DrugRepV_7474	Hypericin	Anticancer	Cutaneous T-cell Lymphoma	West Nile virus	New York		Visual assay	Decrease (50 %)	Investigational	12076755
DrugRepV_7475	Suramin	Antiparasitic products, Insectisides and Repellents	Sleeping sickness | Onchocerciasis	West Nile virus	New York		Visual assay	Decrease (50 %)	Investigational	12076755
DrugRepV_7476	Suramin	Antiparasitic products, Insectisides and Repellents	Sleeping sickness | Onchocerciasis	West Nile virus	Uganda strain B 956		Visual assay	Decrease (50 %)	Investigational	12076755
DrugRepV_7480	5-fluorouridine	NA	Cancer	West Nile virus	New York		Visual assay	Decrease (50 %)	Experimental	12076755
DrugRepV_7482	(S )-DHPA	NA	NA	West Nile virus	New York		Visual assay	Decrease (50 %)	NA	12076755
DrugRepV_7483	(S )-DHPA	NA	NA	West Nile virus	Uganda strain B 956		Visual assay	Decrease (50 %)	NA	12076755
DrugRepV_7484	3-Deazaneplanocin A	NA	NA	West Nile virus	New York		Visual assay	Decrease (50 %)	NA	12076755
DrugRepV_7488	6-Bromotoyocamycin	NA	NA	West Nile virus	New York		Visual assay	Decrease (50 %)	NA	12076755
DrugRepV_7489	Formycin B	NA	NA	West Nile virus	New York		Visual assay	Decrease (50 %)	Experimental	12076755
DrugRepV_7492	2-Thiouracil	NA	NA	West Nile virus	New York		Visual assay	Decrease (50 %)	NA	12076755
DrugRepV_7493	5-Azacytidine	Antineoplastic and Immunomodulating Agents	Anemia	West Nile virus	New York		Visual assay	Decrease (50 %)	Approved	12076755
DrugRepV_7494	Cyclopentyluracil	NA	NA	West Nile virus	New York		Visual assay	Decrease (50 %)	NA	12076755
DrugRepV_7495	Dihydro-5-azacytidine	NA	NA	West Nile virus	New York		Visual assay	Decrease (50 %)	NA	12076755
DrugRepV_7496	Uridine 2,3-dialdehyde	NA	NA	West Nile virus	New York		Visual assay	Decrease (50 %)	NA	12076755
DrugRepV_7502	6-Azauridine	NA	Cancer	West Nile virus	New York		Visual assay	Decrease (50 %)	NA	12076755
DrugRepV_7503	6-Azauridine triacetate	NA	NA	West Nile virus	New York		Visual assay	Decrease (50 %)	NA	12076755
DrugRepV_7504	Pyrazofurin	NA	NA	West Nile virus	New York		Visual assay	Decrease (50 %)	NA	12076755
DrugRepV_7505	Selenazofurin	NA	NA	West Nile virus	New York		Visual assay	Decrease (50 %)	NA	12076755
DrugRepV_7506	Ribavirin	Antiinfectives For Systemic Use	Hepatitis C virus	West Nile virus	New York		Visual assay	Decrease (50 %)	Approved	12076755
DrugRepV_7507	Mycophenolic Acid	Antineoplastic and Immunomodulating Agents	Organ rejection (immunosuppressants)	West Nile virus	New York		Visual assay	Decrease (50 %)	Approved	12076755
DrugRepV_7508	Cyclopentenylcytosine	NA	NA	West Nile virus	New York		Visual assay	Decrease (50 %)	NA	12076755